ORALE KOMPLEMENT-FAKTOR-D-INHIBITOREN
European patent · EP4041238 · In force
Register entry
- Publication number
- EP4041238
- Application number
- EP20874925
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Oct 9, 2020
- Published
- Aug 17, 2022
- Granted
- Jun 3, 2026
- Protection ends at the latest
- Oct 8, 2040
- Next annual fee due
- Oct 31, 2026
- IPC classes
- C07D 405/04 (2006.01)A61K 31/506 (2006.01)A61K 31/519 (2006.01)A61K 31/5377 (2006.01)
- Priority
- US 201962912929 P 09.10.2019
- PCT application
- PCT/US2020/054992 09.10.2020
- PCT publication
- WO2021/072198 15.04.2021
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jun 3, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 03.06.2026
Parties
Inventor
KOTIAN, Pravin L.
Hoover, AL 35226, US
BABU, Yarlagadda S.
Birmingham, AL 35244, US
ZHANG, Weihe
Vestavia Hills, AL 35226, US
LU, Peng-Cheng
Vestavia Hills, AL 35243, US
SPAULDING, Andrew E.
Hoover, AL 35226, US
LV, Wei
Hoover, AL 35244, US
DANG, Zhao
Vestavia Hills, AL 35216, US
RAMAN, Krishnan
Birmingham, AL 35216, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.